Yunqi Capital Comments on Proxy Advisors' Updated Recommendations, Urges Shareholders to Continue to Back the Company's Standalone Trajectory

Core Viewpoint - Yunqi Capital Limited, a 5.1% shareholder of STAAR Surgical Company, has released a letter to STAAR shareholders addressing the recent reports from Institutional Shareholder Services Inc. and Glass, Lewis & Co. regarding the proposed acquisition of STAAR by Alcon Inc. [1] Group 1 - Yunqi Capital is an investment management firm that advises funds and holds a significant stake in STAAR Surgical Company [1] - The letter is a response to updated reports from ISS and Glass Lewis concerning the acquisition proposal [1] - The acquisition by Alcon Inc. is a central topic of discussion in the letter [1]